SEC Form 4 · accession 0001192482-17-000073
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph D Keegan
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.18 | Mar 15, 2017 | A | 10,000 | A | — | Mar 15, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option award vests and becomes exercisable over a one-year period, commencing on March 15, 2017, in twelve equal installments, on the 14th day of each calendar month, subject to the reporting person's continued service with the issuer.